Skip to main content

Funding Calls Database « All Calls

RFA PDAC

Funder(s): Anticancer Fund, Rising Tide Foundation for Clinical Cancer Research,

We are seeking to support clinical trials testing novel and unique strategies in the treatment of patients diagnosed with pancreatic ductal adenocarcinomas (PDAC) and/or biliary tract cancer (BTC)*. The proposal needs to have the potential to have a high impact (e.g. improve cure rate or survival) on the treatment of these cancers.

We are looking for innovative approaches extrapolated from laboratory work in relevant cancer models or extrapolated from other cancer types but deemed applicable in PDAC and/or BTC. Both early phase trials as later phase trials with an out-of-the-box concept are permitted. In principal, generating proof-of concept data or exploring novel promising interventions not investigated yet or building on preliminary pilot data are welcomed. Proposals might not be deemed innovative if the intervention is being or has been investigated by other groups or if there is only a small incremental gain in knowledge and/or outcome.

Timeline & Milestones

Call Open

April 30, 2021

Deadline First stage (LOI / pre-proposal)

June 30, 2021

Announcement of Applicants selected for stage 2

August 16, 2021

Deadline Full Application

October 17, 2023

Grant Decision – Final Decision – Awarding

December 20, 2021

Unfortunatly this funding call is not open for applications.